NEW YORK, Aug. 3 – An investment firm responsible in part for providing seed money for Genomica Corporation has sold its nearly 3 percent stake in the company, it said on Friday. 

Harris & Harris Group, based in New York, sold the 731,111 shares it held for a total price of $1.5 million and earned roughly $2.5 million in net proceeds.  The investment firm said it filed a total long-term net capital gain on the sale of slightly more than $1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.